GlassScriptPhysician profile
Waqas Ullah
NPI 1134656630
$5,195.67
in general payments reported to CMS, 2019-2025
14 companies · $1,433 in 2025
The $1,433 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.62 · 2020: $14.31 · 2021: $276 · 2022: $292 · 2023: $1,657 · 2024: $1,502 · 2025: $1,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,665 · Food and Beverage: $1,406 · Grant: $1,063 · Education: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,664.97 |
| Food and Beverage | $1,405.58 |
| Grant | $1,063.29 |
| Education | $458.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,734.83 | 2019-2025 | Optis, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $1,394.49 | 2024-2025 | Avvigo Guidance System |
| Abiomed | $1,250.83 | 2022-2025 | Impella |
| Medtronic, INC. | $221.24 | 2024 | Onyx Frontier |
| E.R. Squibb & Sons, L.L.C. | $192.58 | 2022 | |
| Novartis Pharmaceuticals Corporation | $80.75 | 2022-2023 | |
| Pfizer INC. | $73.62 | 2023 | |
| Cleerly, INC. | $63.69 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Cook Medical LLC | $48.78 | 2023 | Zenith Alpha |
| Amgen INC. | $46.85 | 2023 | Repatha |
| Edwards Lifesciences Corporation | $31.21 | 2023 | Sapien 3 Ultra Resilia |
| Scpharmaceuticals INC. | $23.25 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.19 | 2025 | Lifevest |
| Lantheus Medical Imaging, INC. | $15.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waqas Ullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.